My research focuses on phytotherapy and natural product pharmacology, with a particular interest in the biological activities of phenolic compounds and medicinal plants from the Lamiaceae and Asteraceae families. I have studied their phytochemical composition and investigated their inhibitory effects on key enzymes, including furin protease, with potential implications in infectious and metabolic diseases. In addition to international work, I have also published a national paper discussing the potential role of luteolin as a therapeutic candidate for COVID-19. Beyond experimental work, I am also interested in advanced analytical methods such as HPLC and spectrophotometry for compound characterization, as well as in exploring synergistic interactions of bioactive compounds through combination index approaches. Academically, I am committed to bridging traditional medicinal knowledge with modern pharmacological evidence, aiming to contribute to both scientific understanding and clinical applications of phytotherapy.